BNP Paribas Financial Markets Purchases 35,570 Shares of The Clorox Company (NYSE:CLX)

BNP Paribas Financial Markets boosted its position in The Clorox Company (NYSE:CLXFree Report) by 20.4% during the fourth quarter, HoldingsChannel reports. The fund owned 210,317 shares of the company’s stock after buying an additional 35,570 shares during the quarter. BNP Paribas Financial Markets’ holdings in Clorox were worth $34,158,000 as of its most recent filing with the SEC.

Several other institutional investors have also added to or reduced their stakes in CLX. Brooklyn Investment Group lifted its stake in shares of Clorox by 163.8% during the 4th quarter. Brooklyn Investment Group now owns 153 shares of the company’s stock valued at $25,000 after buying an additional 95 shares in the last quarter. Redwood Park Advisors LLC bought a new stake in Clorox during the 4th quarter valued at $26,000. Millstone Evans Group LLC purchased a new stake in shares of Clorox during the fourth quarter worth $31,000. Asset Planning Inc bought a new position in shares of Clorox in the fourth quarter worth $32,000. Finally, GKV Capital Management Co. Inc. purchased a new position in shares of Clorox in the fourth quarter valued at $32,000. 78.53% of the stock is owned by hedge funds and other institutional investors.

Clorox Stock Up 0.9 %

CLX opened at $137.75 on Friday. The Clorox Company has a 12 month low of $127.60 and a 12 month high of $171.37. The company has a current ratio of 0.94, a quick ratio of 0.60 and a debt-to-equity ratio of 20.52. The business’s 50-day moving average price is $142.69 and its 200-day moving average price is $154.27. The company has a market cap of $16.97 billion, a P/E ratio of 37.64, a P/E/G ratio of 2.62 and a beta of 0.60.

Clorox (NYSE:CLXGet Free Report) last announced its quarterly earnings data on Monday, May 5th. The company reported $1.45 earnings per share for the quarter, missing the consensus estimate of $1.57 by ($0.12). Clorox had a net margin of 6.38% and a return on equity of 316.87%. The company had revenue of $1.67 billion during the quarter, compared to the consensus estimate of $1.74 billion. During the same quarter in the previous year, the firm posted $1.71 EPS. The business’s revenue for the quarter was down 8.0% compared to the same quarter last year. On average, equities analysts expect that The Clorox Company will post 7.15 EPS for the current year.

Clorox Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, May 9th. Shareholders of record on Wednesday, April 23rd will be given a $1.22 dividend. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.54%. The ex-dividend date of this dividend is Wednesday, April 23rd. Clorox’s payout ratio is 87.61%.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently commented on CLX shares. Royal Bank of Canada restated a “sector perform” rating and issued a $150.00 price objective on shares of Clorox in a research report on Thursday, January 30th. JPMorgan Chase & Co. decreased their price target on shares of Clorox from $151.00 to $144.00 and set a “neutral” rating on the stock in a report on Tuesday. Wells Fargo & Company dropped their price objective on Clorox from $145.00 to $142.00 and set an “equal weight” rating for the company in a research note on Tuesday. Barclays lowered their price target on Clorox from $134.00 to $129.00 and set an “underweight” rating on the stock in a report on Wednesday. Finally, Morgan Stanley decreased their price objective on shares of Clorox from $165.00 to $150.00 and set an “equal weight” rating on the stock in a research report on Tuesday. Three equities research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and one has assigned a buy rating to the company’s stock. Based on data from MarketBeat, Clorox presently has an average rating of “Hold” and a consensus price target of $151.23.

Get Our Latest Analysis on CLX

Clorox Company Profile

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Featured Articles

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLXFree Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.